- Patent Title: Heterocyclic ITK inhibitors for treating inflammation and cancer
-
Application No.: US15005627Application Date: 2016-01-25
-
Publication No.: US09695200B2Publication Date: 2017-07-04
- Inventor: Eric Jon Jacobsen , James Robert Blinn , John Robert Springer , Susan L. Hockerman
- Applicant: Confluence Life Sciences, Inc.
- Applicant Address: US MO St. Louis
- Assignee: Confluence Life Sciences, Inc.
- Current Assignee: Confluence Life Sciences, Inc.
- Current Assignee Address: US MO St. Louis
- Agent Dennis A. Bennett; Brock Levin
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/506 ; C07D471/04 ; A61K45/06 ; A61K31/437 ; C07D519/00
Abstract:
Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of Formula (I): wherein R1, R2, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
Public/Granted literature
- US20160213653A1 HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER Public/Granted day:2016-07-28
Information query
IPC分类:
